Skip to content

XERIANT, INC.: 10-Q filed 2025-05-15

What XERIANT, INC. reported in its quarterly report filed 2025-05-15 (fiscal Q3 2025): 31 published measures, 97 facts as tagged in accession 0001477932-25-003761.

This filing

Form
10-Q (quarterly report)
Filed
2025-05-15
Fiscal period
fiscal Q3 2025
Accession
0001477932-25-003761 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XERIANT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-03-3173,172USD
At 2024-06-30713,005USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-03-318,664,317USD
At 2024-06-309,325,459USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-03-31-5,713,997USD
At 2024-06-30-5,752,513USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-527,656USD90
2024-07-01 to 2025-03-31-1,302,552USD274
2024-01-01 to 2024-03-31-376,327USD91
2023-07-01 to 2024-03-31-1,909,600USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2025-03-31-1,116,530USD274
2023-07-01 to 2024-03-31-1,059,894USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2025-03-31517,000USD274
2023-07-01 to 2024-03-311,380,000USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-07-01 to 2025-03-310USD274
2023-07-01 to 2024-03-31-8,163USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-03-31-28,011,467USD
At 2024-06-30-26,708,915USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-03-31654,797,086shares90
2024-07-01 to 2025-03-31599,035,774shares274
2024-01-01 to 2024-03-31449,266,866shares91
2023-07-01 to 2024-03-31422,070,403shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-310USD/shares274
2024-01-01 to 2024-03-310USD/shares91
2023-07-01 to 2024-03-310USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD90
2024-07-01 to 2025-03-310USD274
2024-01-01 to 2024-03-310USD91
2023-07-01 to 2024-03-310USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-03-312,861USD
At 2024-06-303,995USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-458,918USD90
2024-07-01 to 2025-03-31-1,153,296USD274
2024-01-01 to 2024-03-31-352,964USD91
2023-07-01 to 2024-03-31-1,011,797USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-03-3161,922USD
At 2024-06-30664,211USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-01-01 to 2025-03-3166,153USD90
2024-07-01 to 2025-03-31179,149USD274
2024-01-01 to 2024-03-3128,563USD91
2023-07-01 to 2024-03-31895,891USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-03-318,660,102USD
At 2024-06-309,325,459USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-03-31458,918USD90
2024-07-01 to 2025-03-311,153,296USD274
2024-01-01 to 2024-03-31352,964USD91
2023-07-01 to 2024-03-311,011,797USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-01-01 to 2025-03-3130,224USD90
2024-07-01 to 2025-03-3156,800USD274
2024-01-01 to 2024-03-3167,524USD91
2023-07-01 to 2024-03-31147,259USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-31681,131,059shares
At 2024-06-30524,853,304shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-03-3153,587USD
At 2024-06-30653,117USD
At 2024-03-31373,568USD
At 2023-06-3061,625USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-03-3122,192,742USD
At 2024-06-3020,899,187USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-03-31-8,591,145USD
At 2024-12-31-8,689,477USD
At 2024-09-30-8,497,663USD
At 2024-06-30-8,612,454USD
At 2024-03-31-8,165,329USD
At 2023-12-31-7,847,893USD
At 2023-09-30-6,896,112USD
At 2023-06-30-6,620,100USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-03-318,389USD
At 2024-06-3032,253USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-03-314,215USD
At 2024-06-300USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-03-3150,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-530,268USD90
2024-07-01 to 2025-03-31-1,319,759USD274
2024-01-01 to 2024-03-31-384,096USD91
2023-07-01 to 2024-03-31-1,933,003USD275

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-530,268USD90
2024-07-01 to 2025-03-31-1,319,759USD274
2024-10-01 to 2024-12-31-417,269USD92
2024-07-01 to 2024-09-30-372,222USD92
2024-01-01 to 2024-03-31-384,096USD91
2023-07-01 to 2024-03-31-1,933,003USD275
2023-10-01 to 2023-12-31-1,206,895USD92
2023-07-01 to 2023-09-30-342,012USD92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31102,087USD90
2024-07-01 to 2025-03-31304,153USD274
2024-01-01 to 2024-03-3168,309USD91
2023-07-01 to 2024-03-31193,557USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-71,350USD90
2024-07-01 to 2025-03-31-166,463USD274
2024-01-01 to 2024-03-31-31,132USD91
2023-07-01 to 2024-03-31-921,206USD275

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-07-01 to 2025-03-310USD274
2023-07-01 to 2024-03-310USD275

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2024-07-01 to 2025-03-310USD274
2023-07-01 to 2024-03-310USD275

Inspect the source

Entity
XERIANT, INC. / CIK 0001481504
Captured
2026-09-20T09:08:58.811Z
SEC response SHA-256
24601b8f9caaca687cd26a472196c97b42ac498ab622839dc0af56c4e7e8b865

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001481504.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))